FBFlorence Burté

Florence Burté

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florence Burté has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multidrug Antifungal Resistance and Clinical Outcomes in Fungal Keratitis: A Prospective Study in a South Indian Population

    by Leonie Fingerhut, Ramakrishnan Vigneshwar, Florence Burté, Manojkumar Vimala Devi, Rathinavel Sethu Nagarajan, Rajarathinam Karpagam, Venkatesh Prajna, Bethany Mills, Prajna Lalitha

    Objectives: Our primary objective was to identify the rate of anti-fungal resistance (including multidrug resistance) of fungal isolates cultured from fungal keratitis patients in South India. Our secondary objective was to identify associations between antifungal resistance and patient outcome. Subjects/Methods: 153 patients attending the cornea clinic at Aravind Eye Hospital, Madurai (May – August 2025) with culture positive fungal keratitis were enrolled in the study. Cultured isolates were evaluated for natamycin, amphotericin B, voriconazole and econazole MIC (n=151-153). MIC data were analysed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test. Patient disease outcome relative to isolate resistance was analysed by fisher’s exact test (n=91). Results: There were high levels of resistance to all four antifungals, which were significantly elevated in Fusarium spp. and Aspergillus spp. isolates compared to other fungal genera (PFusarium spp. isolates (n= 81) to: natamycin: 38.3%; amphotericin B: 93.8%; voriconazole: 97.5% and econazole: 76.5%. Resistance of Aspergillus spp. isolates (n=33) to: natamycin: 66.7%; amphotericin B: 87.9%; voriconazole: 6.1%; and econazole: 0%. Overall, fungal resistance to natamycin significantly correlated with a poor clinical outcome, P=0.0034, relative risk 1.7 (95% CI: 1.2-2.6). Conclusions: The majority of fungal isolates were resistant to multiple antifungals; none of the Fusarium isolates were susceptible to all four drugs, 15% were resistant to all of them. Resistance towards natamycin may worsen clinical outcome, particularly for infections caused by Aspergillus , even when susceptible to azoles. Our data supports the need for species specific MIC thresholds to have increased clinical utility.

  • Open Access

    Metabolite profiles of medulloblastoma for rapid and non-invasive detection of molecular disease groups

    by Sarah Kohe, Christopher Bennett, Florence Burté, Magretta Adiamah, Heather Rose, Lara Worthington, Fatma Scerif, Lesley MacPherson, Simrandip Gill, Debbie Hicks, et al.


  • Open Access

    OPA1 disease-causing mutants have domain-specific effects on mitochondrial ultrastructure and fusion

    by Benjamín Cartes-Saavedra, Daniel Lagos, Josefa Macuada, Duxan Arancibia, Florence Burté, Marcela K. Sjöberg-Herrera, María Estela Andrés, Rita Horvath, Patrick Yu-Wai-Man, György Hajnóczky, et al.

    Inner mitochondrial membrane fusion and cristae shape depend on optic atrophy protein 1, OPA1. Mutations in OPA1 lead to autosomal dominant optic atrophy (ADOA), an important cause of inherited blindness. The Guanosin Triphosphatase (GTPase) and GTPase effector domains (GEDs) of OPA1 are essential for mitochondrial fusion; yet, their specific roles remain elusive. Intriguingly, patients carrying OPA1 GTPase mutations have a higher risk of developing more severe multisystemic symptoms in addition to optic atrophy, suggesting pathogenic contributions for the GTPase and GED domains, respectively. We studied OPA1 GTPase and GED mutations to understand their domain-specific contribution to protein function by analyzing patient-derived cells and gain-of-function paradigms. Mitochondria from OPA1 GTPase (c.870+5G>A and c.889C>T) and GED (c.2713C>T and c.2818+5G>A) mutants display distinct aberrant cristae ultrastructure. While all OPA1 mutants inhibited mitochondrial fusion, some GTPase mutants resulted in elongated mitochondria, suggesting fission inhibition. We show that the GED is dispensable for fusion and OPA1 oligomer formation but necessary for GTPase activity. Finally, splicing defect mutants displayed a posttranslational haploinsufficiency-like phenotype but retained domain-specific dysfunctions. Thus, OPA1 domain-specific mutants result in distinct impairments in mitochondrial dynamics, providing insight into OPA1 function and its contribution to ADOA pathogenesis and severity.


  • Open Access

    WFS1-Associated Optic Neuropathy: Genotype-Phenotype Correlations and Disease Progression

    by Anna Majander, Neringa Jurkute, Florence Burté, Kristian Brock, Catarina João, Houbin Huang, Magella M. Neveu, Choi Mun Chan, Holly J. Duncan, Simon Kelly, et al.


  • OPA1 GTPase and GE Domain-Specific Mutations Differentially Alter Mitochondrial Fusion Dynamics and Calcium Homeostasis

    by Benjamin Cartes-Saavedra, Duxan Arancibia, Florence Burté, Marcela Sjoberg, Maria Estela Andres, Patrick Yu-Wai-Man, Gyorgy Hajnoczky, Verónica Eisner


  • Open Access

    Low plasma haptoglobin is a risk factor for life-threatening childhood severe malarial anemia and not an exclusive consequence of hemolysis

    by Samuel Eneọjọ Abah, Florence Burté, Sandrine Marquet, Biobele J. Brown, Francis Akinkunmi, Gbeminiyi Oyinloye, Nathaniel K. Afolabi, Samuel Omokhodion, Ikeoluwa Lagunju, Wuraola A. Shokunbi, et al.

    Severe Malarial Anemia (SMA), a life-threatening childhood Plasmodium falciparum malaria syndrome requiring urgent blood transfusion, exhibits inflammatory and hemolytic pathology. Differentiating between hypo-haptoglobinemia due to hemolysis or that of genetic origin is key to understand SMA pathogenesis. We hypothesized that while malaria-induced hypo-haptoglobinemia should reverse at recovery, that of genetic etiology should not. We carried-out a case-control study of children living under hyper-endemic holoendemic malaria burden in the sub-Saharan metropolis of Ibadan, Nigeria. We show that hypo-haptoglobinemia is a risk factor for childhood SMA and not solely due to intravascular hemolysis from underlying schizogony. In children presenting with SMA, hypo-haptoglobinemia remains through convalescence to recovery suggesting a genetic cause. We identified a haptoglobin gene variant, rs12162087 (g.-1203G > A, frequency = 0.67), to be associated with plasma haptoglobin levels (p = 8.5 × 10−6). The Homo-Var:(AA) is associated with high plasma haptoglobin while the reference Homo-Ref:(GG) is associated with hypo-haptoglobinemia (p = 2.3 × 10−6). The variant is associated with SMA, with the most support for a risk effect for Homo-Ref genotype. Our insights on regulatory haptoglobin genotypes and hypo-haptoglobinemia suggest that haptoglobin screening could be part of risk-assessment algorithms to prevent rapid disease progression towards SMA in regions with no-access to urgent blood transfusion where SMA accounts for high childhood mortality rates.